A Practical Guide for Pediatric Nuclear Medicine. Zvi Bar-Sever, Francesco Giammarile, Ora Israel, Helen Nadel (Editors). OPEN ACCESS Luigi Mansi Book Review 23 November 2023 Pages: 611 - 611
The 16th Hangzhou International Molecular Imaging Conference (HIMIC 2023): the milestone of molecular imaging journey in China Mei TianHong Zhang Editorial 05 December 2023 Pages: 612 - 614
Something still missing in molecular imaging: CXCR2 axis in prostate cancer Luca FilippiLaura Evangelista Editorial 08 November 2023 Pages: 615 - 617
From pixels to predictions: the scrying power of molecular imaging Gaia NinattiCristiano PiniMartina Sollini Editorial 10 November 2023 Pages: 618 - 624
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy Shiyu ZhuBeibei LiangJianguo Lin Original Article 25 October 2023 Pages: 625 - 640
STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy Duo XuXin LuDan Li Original Article 04 November 2023 Pages: 641 - 655
Development of a novel 18F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression Lihong BuXiaowei MaZhen Cheng Original Article 09 November 2023 Pages: 656 - 668
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models Niels BöhnkeBård IndrevollSabine Zitzmann-Kolbe Original Article Open access 26 October 2023 Pages: 669 - 680
Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker? H. S. A. TingenA. TubbenH. L. A. Nienhuis Original Article Open access 16 October 2023 Pages: 681 - 690
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals? Olivier GheysensGiorgio TregliaSharmila Dorbala Editorial 19 December 2023 Pages: 691 - 694
CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients Attila FeherKonrad PieszkoEdward J. Miller Original Article 04 November 2023 Pages: 695 - 706
Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers Henrik Bo Wiberg LarssonIan LawUlrich Lindberg Original Article Open access 16 October 2023 Pages: 707 - 720
Simultaneous high-resolution whole-brain MR spectroscopy and [18F]FDG PET for temporal lobe epilepsy Hui HuangMiao ZhangJie Luo Original Article 12 October 2023 Pages: 721 - 733
Impact of simulated reduced injected dose on the assessment of amyloid PET scans Peter YoungFiona Heemanon behalf of the AMYPAD consortium Original Article Open access 28 October 2023 Pages: 734 - 748
Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG Aleksander KosmalaJohannes DuellRudolf A. Werner Original Article Open access 09 November 2023 Pages: 749 - 755
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy Arnoldo PiccardoGiorgio TregliaPietro Zucchetta Review Article Open access 14 November 2023 Pages: 756 - 767
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts Hanna BerglundSara Lundsten SalomonssonMarika Nestor Original Article Open access 12 October 2023 Pages: 768 - 778
Exploring the association of glioma tumor residuals from incongruent [18F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram Xiaoran LiYe ChengJie Lu Original Article 21 October 2023 Pages: 779 - 796
[18F]FET PET/MR and machine learning in the evaluation of glioma Leandra PiscopoEmilia ZampellaMichele Klain Editorial 13 November 2023 Pages: 797 - 799
PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer Leandra PiscopoFabio Volpe Editorial 27 September 2023 Pages: 800 - 802
Letter to the Editor: Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer Fernanda Miyuki SasakiAline Lopes Garcia LealFelipe Alves Mourato Letter to the Editor 29 November 2023 Pages: 803 - 804
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment Madhav P. YadavSanjana BallalChandrasekhar Bal Original Article 07 November 2023 Pages: 805 - 819
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy H. SiebingaJ. J. M. A. HendrikxB. J. de Wit-van der Veen Short Communication 16 October 2023 Pages: 820 - 827
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors Duygu Has SimsekYunus GuzelSerkan Kuyumcu Original Article 10 November 2023 Pages: 828 - 840
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT Manuel WeberOlof PetterssonAnders Sundin Original Article Open access 10 November 2023 Pages: 841 - 851
The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study Caner CivanSerkan KuyumcuYasemin Sanli Original Article 07 October 2023 Pages: 852 - 861
FAPI PET/CT: a new kid on the block for RCC Cristian UdovicichMarlon PereraShankar Siva Editorial 22 December 2023 Pages: 862 - 863
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients Matteo BaucknehtEnrico CheccucciFrancesco Porpiglia Short Communication 08 November 2023 Pages: 864 - 870
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer Jie ZangGuochang WangJingjing Zhang Original Article 21 October 2023 Pages: 871 - 882
Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule Davide BiancoCarmela NappiMichele Klain Editorial 21 November 2023 Pages: 883 - 884
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry Caroline BurgardConnor HeinFlorian Rosar Original Article Open access 27 October 2023 Pages: 885 - 895
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs Ruohua ChenYee Ling NgJianjun Liu Original Article 27 October 2023 Pages: 896 - 906
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial Samuele GhezzoPaola MapelliMaria Picchio Original Article 28 October 2023 Pages: 907 - 918
A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging Jing LvHaojun YuHongcheng Shi Original Article 09 November 2023 Pages: 919 - 927
Pigmented villonodular synovitis detected by [68Ga]Ga-FAPI-04 PET/CT Chunmei GuoLingzhi LiZhanwen Huang Image of the Month 27 October 2023 Pages: 928 - 929
Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET Tadashi WatabeIvan Ray DavidFrederik L. Giesel Image of the Month Open access 28 October 2023 Pages: 930 - 931